General information

From May 1st 2026, VEOZA® 45 mg is fully reimbursed by the health insurance (exclusively for an insured person with moderate to severe vasomotor symptoms associated with menopause and a contraindication to hormone replacement therapy). For this reason the reimbursement scheme for VEOZA® will terminate the 1st of May 2026.

Dose VEOZA® 45mg
Type Tablets
Active ingredient FEZOLINETANT

Reimbursement

Conditions

The Personal Contribution for VEOZA® that is demonstrably charged to the patient was fully reimbursed until May 1st 2026. Prescriptions dispensed until May 1st 2026 can be claimed through TerugBetaalRegeling Nederland until July 31st 2026.

Who can submit a claim

  1. Patients or their caregiver can declare the Personal Contribution for VEOZA® 45mg online 
  2. Pharmacists can only declare this medicine online on behalf of the patient.

From when till when can you submit a claim

Claims with an issue date before the 1 st of May 2026 can be processed by TBR Nederland until July 31, 2026.

Submit a claim online

Patients and pharamcists can claim online and will receive the reimbursement within 5 working days.

Read our tips on how to submit a claim online

Login & Submit a Claim          Open an Online Account

 


MAT-NL-VEO-2026-00024

Instructional videos

Watch our instructional videos for more information about creating an account and making a claim 

Watch the videos

PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS

Check your medicine expenses

Quickly check the maximum contribution you have to pay for your medicine

Check Medicine Expenses

You are currently offline. Some pages or content may fail to load.